Followers | 145 |
Posts | 27565 |
Boards Moderated | 3 |
Alias Born | 02/07/2004 |
Monday, October 10, 2016 6:35:03 AM
of "breakthrough treatment"
The company owned by Elbit Medical (25%) received
the classification for the Nicord due to improved absorption of blood cells in bone marrow transplantation in patients with malignant blood diseases
Elbit Medical Technologies reports that Gamida Ltd. held by the Company at the rate of 25% (22.5% fully diluted), announced that the Food and Drug Administration (FDA) has granted the classification of "breakthrough treatment" of the drug Nicord due to improved absorption of neutrophil blood cells by bone marrow transplant in patients with malignant blood diseases.
[Google auto translate]
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM